The Enterprise Value as of June 2026 (TTM) for Liminal BioSciences Inc. (LMNL) is 2.90M

According to Liminal BioSciences Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 2.90M. This represents a change of -109.94% compared to the average of -29133350.99 of the last 4 quarters.

Liminal BioSciences Inc. (LMNL) Historical Enterprise Value (quarterly & annually)

How has LMNL Enterprise Value performed in the past?

The mean historical Enterprise Value of Liminal BioSciences Inc. over the last ten years is 618.75M. The current 2.90M Enterprise Value has changed -53.18% with respect to the historical average. Over the past ten years (40 quarters), LMNL's Enterprise Value was at its highest in in the December 2015 quarter at 1.96B. The Enterprise Value was at its lowest in in the September 2021 quarter at -51053858.19.

Liminal BioSciences Inc. (LMNL) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Liminal BioSciences Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Liminal BioSciences Inc. (LMNL) Average Enterprise Value

How has LMNL Enterprise Value performed in the past?

The current Enterprise Value of Liminal BioSciences Inc. (LMNL) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Liminal BioSciences Inc. (LMNL) Enterprise Value vs. Peers

How is LMNL’s Enterprise Value compared to its peers?

Liminal BioSciences Inc.’s Enterprise Value is greater than Freeline Therapeutics Holdings plc (-13071904.00), greater than Serina Therapeutics, Inc. (-1423667.00), less than AnPac Bio-Medical Science Co., Ltd. (192.85M), less than LakeShore Biopharma Co., Ltd (405.82M), less than Allakos Inc. (5.52M), less than Angion Biomedica Corp. (20.03M), less than Marinus Pharmaceuticals, Inc. (20.16M), greater than Vincerx Pharma, Inc. (-4368431.00), less than Opus Genetics, Inc. (294.81M), less than Traws Pharma, Inc. (8.57M),

Build a custom stock screener for Liminal BioSciences Inc. (LMNL) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Liminal BioSciences Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Liminal BioSciences Inc. (LMNL) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Liminal BioSciences Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.